Worth reading
63In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
35.8
％Wording
Definitive
How definitive the wording is.Revised forecast
2024 年３月期 · Full yearPrevious forecast published 2023 年 11 月 14 日Net Sales82,300→82,302million
0.0%
Operating profit3,000→3,753million
+25.1%
Ordinary income4,400→5,974million
+35.8%
Profit attributable to owners of the parent3,500→4,190million
+19.7%
Net income per share—→—yen and sen
—
The bar length represents the relative magnitude of change, based on the item that changed the most in this document.
Reason for the revision
新型コロナウイルス感染症の感染症法上の位置づけが2類相当から5類感染症に変更され行動制限がなくなったことから、国内外食事業がコロナ前の水準に向けて徐々に回復し、売上高が増加したこと、これまで進めてきた生産性向上と固定費削減により業績が回復したため。
Previous-period results売上高77,922百万円、営業利益1,474百万円、経常利益3,883百万円、親会社株主に帰属する当期純利益1,674百万円、１株当たり当期純利益41 円 27 銭（2023 年３月期）
Consolidated / non-consolidatedConsolidated
| Item | Details |
|---|---|
| Net Sales | ¥82,300 million → ¥82,302 million（0.0%） |
| Operating profit | ¥3,000 million → ¥3,753 million（+25.1%） |
| Ordinary income | ¥4,400 million → ¥5,974 million（+35.8%） |
| Profit attributable to owners of the parent | ¥3,500 million → ¥4,190 million（+19.7%） |
| Net income per share | 87 円 48 銭 → 92 円 67 銭 |
| Fiscal Period Covered | 2024 年３月期 |
| Period Covered | Full year |
| Publication date of previous forecast | 2023 年 11 月 14 日 |
| Previous-period results | 売上高77,922百万円、営業利益1,474百万円、経常利益3,883百万円、親会社株主に帰属する当期純利益1,674百万円、１株当たり当期純利益41 円 27 銭（2023 年３月期） |
| Reason for the revision | 新型コロナウイルス感染症の感染症法上の位置づけが2類相当から5類感染症に変更され行動制限がなくなったことから、国内外食事業がコロナ前の水準に向けて徐々に回復し、売上高が増加したこと、これまで進めてきた生産性向上と固定費削減により業績が回復したため。 |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
Details and amount of extraordinary lossDividend forecast revision
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.新型コロナウイルス感染症の感染症法上の位置づけが2類相当から5類感染症に変更され、行動制限がなくなったことで国内外食事業が回復し、売上高が増加したことに加え、生産性向上や固定費削減を進めたため。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.